US Stock MarketDetailed Quotes

PMCB PharmaCyte Biotech

Watchlist

1.660
-0.200-10.75%

Close Aug 23 16:00 ET

12.80MMarket Cap-922P/E (TTM)

PharmaCyte Biotech Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual

YOY

Hide blank lines

(FY)Apr 30, 2024

(Q4)Apr 30, 2024

(Q3)Jan 31, 2024

(Q2)Oct 31, 2023

(Q1)Jul 31, 2023

(FY)Apr 30, 2023

(Q4)Apr 30, 2023

(Q3)Jan 31, 2023

(Q2)Oct 31, 2022

(Q1)Jul 31, 2022

Total revenue

Operating revenue

--0

Cost of revenue

Gross profit

Operating expense

1.00%6.52M

29.11%1.17M

20.35%1.87M

-39.21%1.41M

23.49%2.08M

46.98%6.46M

-40.09%903.28K

81.40%1.55M

130.74%2.32M

64.23%1.68M

Selling and administrative expenses

0.80%4.79M

49.35%839.55K

-10.72%1.12M

-36.89%1.1M

45.01%1.73M

120.37%4.75M

10.25%562.15K

191.44%1.26M

187.82%1.74M

95.40%1.19M

-General and administrative expense

0.80%4.79M

49.35%839.55K

-10.72%1.12M

-36.89%1.1M

45.01%1.73M

120.37%4.75M

10.25%562.15K

191.44%1.26M

187.82%1.74M

95.40%1.19M

Research and development costs

-13.04%407.43K

9.68%94.18K

179.19%126.73K

-53.91%82.03K

-34.40%104.48K

-32.19%468.54K

-66.20%85.87K

-71.28%45.39K

31.63%178K

10.90%159.27K

Other operating expenses

7.08%1.32M

-8.92%232.48K

146.77%620.78K

-42.77%229.16K

-26.77%240K

-20.05%1.23M

-65.68%255.26K

-5.82%251.56K

51.10%400.42K

21.88%327.72K

Operating profit

-1.00%-6.52M

-29.11%-1.17M

-20.35%-1.87M

39.21%-1.41M

-23.49%-2.08M

-46.98%-6.46M

40.09%-903.28K

-81.40%-1.55M

-130.74%-2.32M

-64.23%-1.68M

Net non-operating interest income expense

75.42%3.4M

3.34%747.1K

38.65%881.66K

103.61%894.18K

527.86%875.88K

1,133.01%1.94M

735.12%722.94K

1,298.82%635.89K

1,617.05%439.17K

29,971.95%139.5K

Non-operating interest income

75.42%3.4M

3.34%747.1K

38.65%881.66K

103.61%894.18K

527.86%875.88K

1,129.03%1.94M

735.12%722.94K

1,298.82%635.89K

1,614.24%439.17K

--139.5K

Other net income (expense)

1,610.36%3.45M

3,169.55%1.77M

140.42%367.75K

312,504.06%3.31M

-50,689.78%-1.98M

4,816.37%202K

3,533.44%54.01K

24,379.05%152.96K

-120.42%-1.06K

-144.13%-3.91K

Gain on sale of security

--2.91M

--552K

---268K

--4.08M

---1.45M

----

Special income (charges)

---3.57M

----

--0

----

-Less:Impairment of capital assets

--2M

----

--0

----

-Write off

--1.57M

----

--0

----

Other non- operating income (expenses)

1,939.66%4.12M

8,761.67%4.79M

315.64%635.75K

-72,656.62%-769.77K

-13,516.21%-531.85K

4,816.37%202K

3,533.44%54.01K

24,379.05%152.96K

-120.42%-1.06K

-144.13%-3.91K

Income before tax

107.73%333.76K

1,165.95%1.35M

18.92%-619.54K

248.36%2.79M

-106.04%-3.18M

-1.81%-4.32M

91.12%-126.34K

5.81%-764.14K

-91.94%-1.88M

-50.67%-1.55M

Income tax

Net income

107.73%333.76K

1,165.95%1.35M

18.92%-619.54K

248.36%2.79M

-106.04%-3.18M

-1.81%-4.32M

91.12%-126.34K

5.81%-764.14K

-91.94%-1.88M

-50.67%-1.55M

Net income continuous Operations

107.73%333.76K

1,165.95%1.35M

18.92%-619.54K

248.36%2.79M

-106.04%-3.18M

-1.81%-4.32M

91.12%-126.34K

5.81%-764.14K

-91.94%-1.88M

-50.67%-1.55M

Minority interest income

Net income attributable to the parent company

107.73%333.76K

1,165.95%1.35M

18.92%-619.54K

248.36%2.79M

-106.04%-3.18M

-1.81%-4.32M

91.12%-126.34K

5.81%-764.14K

-91.94%-1.88M

-50.67%-1.55M

Preferred stock dividends

2.52M

829.4K

781.51K

586.89K

319.85K

Other preferred stock dividends

15.05M

3.06M

4.22M

4.46M

Net income attributable to common stockholders

-299.38%-17.24M

-1,910.91%-2.54M

-635.49%-5.62M

-20.08%-2.26M

-126.74%-3.5M

-1.81%-4.32M

91.12%-126.34K

5.81%-764.14K

-91.94%-1.88M

-50.67%-1.55M

Basic earnings per share

-718.18%-1.8

-3,200.00%-0.33

-1,525.00%-0.65

-188.89%-0.26

-300.00%-0.28

18.52%-0.22

83.33%-0.01

0.00%-0.04

-50.00%-0.09

89.06%-0.07

Diluted earnings per share

-718.18%-1.8

-3,200.00%-0.33

-1,525.00%-0.65

-188.89%-0.26

-300.00%-0.28

18.52%-0.22

83.33%-0.01

0.00%-0.04

-50.00%-0.09

89.06%-0.07

Dividend per share

Currency Unit

USD

Audit Opinions

Unqualified Opinion

	(FY)Apr 30, 2024	(Q4)Apr 30, 2024	(Q3)Jan 31, 2024	(Q2)Oct 31, 2023	(Q1)Jul 31, 2023	(FY)Apr 30, 2023	(Q4)Apr 30, 2023	(Q3)Jan 31, 2023	(Q2)Oct 31, 2022	(Q1)Jul 31, 2022
Total revenue	0	0	0	0	0	0	0	0	0	0
Operating revenue	--0	--0	--0	--0	--0	--0	--0	--0	--0	--0
Cost of revenue
Gross profit
Operating expense	1.00%6.52M	29.11%1.17M	20.35%1.87M	-39.21%1.41M	23.49%2.08M	46.98%6.46M	-40.09%903.28K	81.40%1.55M	130.74%2.32M	64.23%1.68M
Selling and administrative expenses	0.80%4.79M	49.35%839.55K	-10.72%1.12M	-36.89%1.1M	45.01%1.73M	120.37%4.75M	10.25%562.15K	191.44%1.26M	187.82%1.74M	95.40%1.19M
-General and administrative expense	0.80%4.79M	49.35%839.55K	-10.72%1.12M	-36.89%1.1M	45.01%1.73M	120.37%4.75M	10.25%562.15K	191.44%1.26M	187.82%1.74M	95.40%1.19M
Research and development costs	-13.04%407.43K	9.68%94.18K	179.19%126.73K	-53.91%82.03K	-34.40%104.48K	-32.19%468.54K	-66.20%85.87K	-71.28%45.39K	31.63%178K	10.90%159.27K
Other operating expenses	7.08%1.32M	-8.92%232.48K	146.77%620.78K	-42.77%229.16K	-26.77%240K	-20.05%1.23M	-65.68%255.26K	-5.82%251.56K	51.10%400.42K	21.88%327.72K
Operating profit	-1.00%-6.52M	-29.11%-1.17M	-20.35%-1.87M	39.21%-1.41M	-23.49%-2.08M	-46.98%-6.46M	40.09%-903.28K	-81.40%-1.55M	-130.74%-2.32M	-64.23%-1.68M
Net non-operating interest income expense	75.42%3.4M	3.34%747.1K	38.65%881.66K	103.61%894.18K	527.86%875.88K	1,133.01%1.94M	735.12%722.94K	1,298.82%635.89K	1,617.05%439.17K	29,971.95%139.5K
Non-operating interest income	75.42%3.4M	3.34%747.1K	38.65%881.66K	103.61%894.18K	527.86%875.88K	1,129.03%1.94M	735.12%722.94K	1,298.82%635.89K	1,614.24%439.17K	--139.5K
Other net income (expense)	1,610.36%3.45M	3,169.55%1.77M	140.42%367.75K	312,504.06%3.31M	-50,689.78%-1.98M	4,816.37%202K	3,533.44%54.01K	24,379.05%152.96K	-120.42%-1.06K	-144.13%-3.91K
Gain on sale of security	--2.91M	--552K	---268K	--4.08M	---1.45M	----	----	----	----	----
Special income (charges)	---3.57M	----	----	----	----	--0	----	----	----	----
-Less:Impairment of capital assets	--2M	----	----	----	----	--0	----	----	----	----
-Write off	--1.57M	----	----	----	----	--0	----	----	----	----
Other non- operating income (expenses)	1,939.66%4.12M	8,761.67%4.79M	315.64%635.75K	-72,656.62%-769.77K	-13,516.21%-531.85K	4,816.37%202K	3,533.44%54.01K	24,379.05%152.96K	-120.42%-1.06K	-144.13%-3.91K
Income before tax	107.73%333.76K	1,165.95%1.35M	18.92%-619.54K	248.36%2.79M	-106.04%-3.18M	-1.81%-4.32M	91.12%-126.34K	5.81%-764.14K	-91.94%-1.88M	-50.67%-1.55M
Income tax
Net income	107.73%333.76K	1,165.95%1.35M	18.92%-619.54K	248.36%2.79M	-106.04%-3.18M	-1.81%-4.32M	91.12%-126.34K	5.81%-764.14K	-91.94%-1.88M	-50.67%-1.55M
Net income continuous Operations	107.73%333.76K	1,165.95%1.35M	18.92%-619.54K	248.36%2.79M	-106.04%-3.18M	-1.81%-4.32M	91.12%-126.34K	5.81%-764.14K	-91.94%-1.88M	-50.67%-1.55M
Minority interest income
Net income attributable to the parent company	107.73%333.76K	1,165.95%1.35M	18.92%-619.54K	248.36%2.79M	-106.04%-3.18M	-1.81%-4.32M	91.12%-126.34K	5.81%-764.14K	-91.94%-1.88M	-50.67%-1.55M
Preferred stock dividends	2.52M	829.4K	781.51K	586.89K	319.85K
Other preferred stock dividends	15.05M	3.06M	4.22M	4.46M		0	0	0	0
Net income attributable to common stockholders	-299.38%-17.24M	-1,910.91%-2.54M	-635.49%-5.62M	-20.08%-2.26M	-126.74%-3.5M	-1.81%-4.32M	91.12%-126.34K	5.81%-764.14K	-91.94%-1.88M	-50.67%-1.55M
Basic earnings per share	-718.18%-1.8	-3,200.00%-0.33	-1,525.00%-0.65	-188.89%-0.26	-300.00%-0.28	18.52%-0.22	83.33%-0.01	0.00%-0.04	-50.00%-0.09	89.06%-0.07
Diluted earnings per share	-718.18%-1.8	-3,200.00%-0.33	-1,525.00%-0.65	-188.89%-0.26	-300.00%-0.28	18.52%-0.22	83.33%-0.01	0.00%-0.04	-50.00%-0.09	89.06%-0.07
Dividend per share
Currency Unit	USD	USD	USD	USD	USD	USD	USD	USD	USD	USD
Audit Opinions	Unqualified Opinion	--	--	--	--	Unqualified Opinion	--	--	--	--

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List

Overall